scholarly journals Integrative analysis of sequencing and array genotype data for discovering disease associations with rare mutations

2015 ◽  
Vol 112 (4) ◽  
pp. 1019-1024 ◽  
Author(s):  
Yi-Juan Hu ◽  
Yun Li ◽  
Paul L. Auer ◽  
Dan-Yu Lin
Keyword(s):  
Type I Error ◽  
Rare Variants ◽  
Extreme Values ◽  
Association Studies ◽  
Cost Effective ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Score Statistic ◽  
Sequencing Data ◽  
Association Tests

In the large cohorts that have been used for genome-wide association studies (GWAS), it is prohibitively expensive to sequence all cohort members. A cost-effective strategy is to sequence subjects with extreme values of quantitative traits or those with specific diseases. By imputing the sequencing data from the GWAS data for the cohort members who are not selected for sequencing, one can dramatically increase the number of subjects with information on rare variants. However, ignoring the uncertainties of imputed rare variants in downstream association analysis will inflate the type I error when sequenced subjects are not a random subset of the GWAS subjects. In this article, we provide a valid and efficient approach to combining observed and imputed data on rare variants. We consider commonly used gene-level association tests, all of which are constructed from the score statistic for assessing the effects of individual variants on the trait of interest. We show that the score statistic based on the observed genotypes for sequenced subjects and the imputed genotypes for nonsequenced subjects is unbiased. We derive a robust variance estimator that reflects the true variability of the score statistic regardless of the sampling scheme and imputation quality, such that the corresponding association tests always have correct type I error. We demonstrate through extensive simulation studies that the proposed tests are substantially more powerful than the use of accurately imputed variants only and the use of sequencing data alone. We provide an application to the Women’s Health Initiative. The relevant software is freely available.

scholarly journals Operating Characteristics of the Rank-Based Inverse Normal Transformation for Quantitative Trait Analysis in Genome-Wide Association Studies

2019 ◽  
Author(s):  
Zachary R. McCaw ◽  
Jacqueline M. Lane ◽  
Richa Saxena ◽  
Susan Redline ◽  
Xihong Lin
Keyword(s):  
Type I Error ◽  
Association Studies ◽  
Genome Wide Association ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Operating Characteristics ◽  
Association Tests ◽  
Genome Wide ◽  
Normal Transformation ◽  
Normally Distributed

SummaryQuantitative traits analyzed in Genome-Wide Association Studies (GWAS) are often non-normally distributed. For such traits, association tests based on standard linear regression are subject to reduced power and inflated type I error in finite samples. Applying the rank-based Inverse Normal Transformation (INT) to non-normally distributed traits has become common practice in GWAS. However, the different variations on INT-based association testing have not been formally defined, and guidance is lacking on when to use which approach. In this paper, we formally define and systematically compare the direct (D-INT) and indirect (I-INT) INT-based association tests. We discuss their assumptions, underlying generative models, and connections. We demonstrate that the relative powers of D-INT and I-INT depend on the underlying data generating process. Since neither approach is uniformly most powerful, we combine them into an adaptive omnibus test (O-INT). O-INT is robust to model misspecification, protects the type I error, and is well powered against a wide range of non-normally distributed traits. Extensive simulations were conducted to examine the finite sample operating characteristics of these tests. Our results demonstrate that, for non-normally distributed traits, INT-based tests outperform the standard untransformed association test (UAT), both in terms of power and type I error rate control. We apply the proposed methods to GWAS of spirometry traits in the UK Biobank. O-INT has been implemented in the R package RNOmni, which is available on CRAN.

Exome-Wide Pan-Cancer Analysis of Germline Variants in 8,719 Individuals Finds Little Evidence of Rare Variant Associations

2021 ◽  
pp. 1-10
Author(s):  
Zoe Guan ◽  
Ronglai Shen ◽  
Colin B. Begg
Keyword(s):  
Rare Variant ◽  
Rare Variants ◽  
Association Studies ◽  
The Cancer Genome Atlas ◽  
Considerable Proportion ◽  
Genome Wide Association Studies ◽  
Sequencing Data ◽  
Risk Variants ◽  
Cancer Types ◽  
Pan Cancer

<b><i>Background:</i></b> Many cancer types show considerable heritability, and extensive research has been done to identify germline susceptibility variants. Linkage studies have discovered many rare high-risk variants, and genome-wide association studies (GWAS) have discovered many common low-risk variants. However, it is believed that a considerable proportion of the heritability of cancer remains unexplained by known susceptibility variants. The “rare variant hypothesis” proposes that much of the missing heritability lies in rare variants that cannot reliably be detected by linkage analysis or GWAS. Until recently, high sequencing costs have precluded extensive surveys of rare variants, but technological advances have now made it possible to analyze rare variants on a much greater scale. <b><i>Objectives:</i></b> In this study, we investigated associations between rare variants and 14 cancer types. <b><i>Methods:</i></b> We ran association tests using whole-exome sequencing data from The Cancer Genome Atlas (TCGA) and validated the findings using data from the Pan-Cancer Analysis of Whole Genomes Consortium (PCAWG). <b><i>Results:</i></b> We identified four significant associations in TCGA, only one of which was replicated in PCAWG (BRCA1 and ovarian cancer). <b><i>Conclusions:</i></b> Our results provide little evidence in favor of the rare variant hypothesis. Much larger sample sizes may be needed to detect undiscovered rare cancer variants.

scholarly journals Efficient phasing and imputation of low-coverage sequencing data using large reference panels

2020 ◽  
Author(s):  
S. Rubinacci ◽  
D.M. Ribeiro ◽  
R. Hofmeister ◽  
O. Delaneau
Keyword(s):  
Paradigm Shift ◽  
Rare Variants ◽  
Association Studies ◽  
Cost Effective ◽  
Human Populations ◽  
Sequencing Data ◽  
Snp Arrays ◽  
Genomic Studies ◽  
Low Coverage ◽  
The Impact

AbstractLow-coverage whole genome sequencing followed by imputation has been proposed as a cost-effective genotyping approach for disease and population genetics studies. However, its competitiveness against SNP arrays is undermined as current imputation methods are computationally expensive and unable to leverage large reference panels.Here, we describe a method, GLIMPSE, for phasing and imputation of low-coverage sequencing datasets from modern reference panels. We demonstrate its remarkable performance across different coverages and human populations. It achieves imputation of a full genome for less than $1, outperforming existing methods by orders of magnitude, with an increased accuracy of more than 20% at rare variants. We also show that 1x coverage enables effective association studies and is better suited than dense SNP arrays to access the impact of rare variations. Overall, this study demonstrates the promising potential of low-coverage imputation and suggests a paradigm shift in the design of future genomic studies.

De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes

2021 ◽  
Vol 118 (47) ◽  
pp. e2112032118
Author(s):  
Anne-Perrine Foray ◽  
Sophie Candon ◽  
Sara Hildebrand ◽  
Cindy Marquet ◽  
Fabrice Valette ◽  
...  
Keyword(s):  
Rare Variants ◽  
De Novo ◽  
Association Studies ◽  
Nod Mice ◽  
Individual Risk ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Dual Specificity Phosphatase ◽  
Dual Specificity ◽  
Significant Difference

Insulin-dependent or type 1 diabetes (T1D) is a polygenic autoimmune disease. In humans, more than 60 loci carrying common variants that confer disease susceptibility have been identified by genome-wide association studies, with a low individual risk contribution for most variants excepting those of the major histocompatibility complex (MHC) region (40 to 50% of risk); hence the importance of missing heritability due in part to rare variants. Nonobese diabetic (NOD) mice recapitulate major features of the human disease including genetic aspects with a key role for the MHC haplotype and a series of Idd loci. Here we mapped in NOD mice rare variants arising from genetic drift and significantly impacting disease risk. To that aim we established by selective breeding two sublines of NOD mice from our inbred NOD/Nck colony exhibiting a significant difference in T1D incidence. Whole-genome sequencing of high (H)- and low (L)-incidence sublines (NOD/NckH and NOD/NckL) revealed a limited number of subline-specific variants. Treating age of diabetes onset as a quantitative trait in automated meiotic mapping (AMM), enhanced susceptibility in NOD/NckH mice was unambiguously attributed to a recessive missense mutation of Dusp10, which encodes a dual specificity phosphatase. The causative effect of the mutation was verified by targeting Dusp10 with CRISPR-Cas9 in NOD/NckL mice, a manipulation that significantly increased disease incidence. The Dusp10 mutation resulted in islet cell down-regulation of type I interferon signature genes, which may exert protective effects against autoimmune aggression. De novo mutations akin to rare human susceptibility variants can alter the T1D phenotype.

scholarly journals MARS: leveraging allelic heterogeneity to increase power of association testing

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Farhad Hormozdiari ◽  
Junghyun Jung ◽  
Eleazar Eskin ◽  
Jong Wha J. Joo
Keyword(s):  
Type I Error ◽  
Association Studies ◽  
Simulated Data ◽  
Real Data ◽  
Association Test ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Association Testing ◽  
Causal Status ◽  
Causal Variants

AbstractIn standard genome-wide association studies (GWAS), the standard association test is underpowered to detect associations between loci with multiple causal variants with small effect sizes. We propose a statistical method, Model-based Association test Reflecting causal Status (MARS), that finds associations between variants in risk loci and a phenotype, considering the causal status of variants, only requiring the existing summary statistics to detect associated risk loci. Utilizing extensive simulated data and real data, we show that MARS increases the power of detecting true associated risk loci compared to previous approaches that consider multiple variants, while controlling the type I error.

scholarly journals Mendelian Randomization Analysis Using Multiple Biomarkers of an Underlying Common Exposure

2021 ◽  
Author(s):  
Jin Jin ◽  
Guanghao Qi ◽  
Zhi Yu ◽  
Nilanjan Chatterjee
Keyword(s):  
Structural Equation ◽  
Type I Error ◽  
Mendelian Randomization ◽  
Causal Effect ◽  
Association Studies ◽  
Error Rates ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Increased Risk ◽  
Multiple Biomarkers

AbstractMendelian Randomization (MR) analysis is increasingly popular for testing the causal effect of exposures on disease outcomes using data from genome-wide association studies. In some settings, the underlying exposure, such as systematic inflammation, may not be directly observable, but measurements can be available on multiple biomarkers, or other types of traits, that are co-regulated by the exposure. We propose method MRLE, which tests the significance for, and the direction of, the effect of a latent exposure by leveraging information from multiple related traits. The method is developed by constructing a set of estimating functions based on the second-order moments of summary association statistics, under a structural equation model where genetic variants are assumed to have indirect effects through the latent exposure and potentially direct effects on the traits. Simulation studies showed that MRLE has well-controlled type I error rates and increased power compared to single-trait MR tests under various types of pleiotropy. Applications of MRLE using genetic association statistics across five inflammatory biomarkers (CRP, IL-6, IL-8, TNF-α and MCP-1) provided evidence for potential causal effects of inflammation on increased risk of coronary artery disease, colorectal cancer and rheumatoid arthritis, while standard MR analysis for individual biomarkers often failed to detect consistent evidence for such effects.

scholarly journals Gene-Based Association Tests Using GWAS Summary Statistics and Incorporating eQTL

2021 ◽  
Author(s):  
Xuewei Cao ◽  
Xuexia Wang ◽  
Shuanglin Zhang ◽  
Qiuying Sha
Keyword(s):  
Genetic Variants ◽  
Association Studies ◽  
Complex Diseases ◽  
Gaussian Copula ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Summary Statistics ◽  
Association Tests ◽  
Aggregate Information ◽  
Alternative Approach

Abstract Although genome-wide association studies (GWAS) have been successfully applied to a variety of complex diseases and identified many genetic variants underlying complex diseases, there is still a considerable heritability of complex diseases that could not be explained by GWAS. One alternative approach to overcome the missing heritability caused by the genetic heterogeneity is gene-based analysis, which considers the aggregate effects of multiple genetic variants in a single test. Another alternative approach is transcriptome-wide association study (TWAS). TWAS aggregates genomic information into functionally relevant units that map to genes and their expression. TWAS is not only powerful, but can also increase the interpretability in biological mechanisms of identified trait associated genes. In this study, we propose two powerful and computationally efficient gene-based association tests, Overall and Copula. These two tests aggregate information from three traditional types of gene-based association tests and also incorporate expression quantitative trait locus (eQTL) data into GWAS using GWAS summary statistics. Overall utilizes the extended Simes procedure and Copula utilizes the Gaussian copula approximation-based method. We show that after a small number of replications to estimate the correlation among the integrated gene-based tests, the P values of these two methods can be calculated analytically. Simulation studies show that these two tests can control type I error rate very well and have higher power than the tests that we compared. We also apply these two methods to two schizophrenia GWAS summary datasets and two lipids GWAS summary datasets. The results show that these two newly developed methods can identify more significant genes than other methods we compared with.

scholarly journals Multi-trait genome-wide analyses of the brain imaging phenotypes in UK Biobank

2019 ◽  
Author(s):  
Chong Wu
Keyword(s):  
Type I Error ◽  
Association Studies ◽  
Error Rates ◽  
Type I ◽  
Genome Wide Association Studies ◽  
Uk Biobank ◽  
Type I Error Rates ◽  
Trait Association ◽  
Genome Wide ◽  
Inflation Factor

AbstractMany genetic variants identified in genome-wide association studies (GWAS) are associated with multiple, sometimes seemingly unrelated traits. This motivates multi-trait association analyses, which have successfully identified novel associated loci for many complex diseases. While appealing, most existing methods focus on analyzing a relatively small number of traits and may yield inflated Type I error rates when a large number of traits need to be analyzed jointly. As deep phenotyping data are becoming rapidly available, we develop a novel method, referred to as aMAT (adaptive multi-trait association test), for multi-trait analysis of any number of traits. We applied aMAT to GWAS summary statistics for a set of 58 volumetric imaging derived phenotypes from the UK Biobank. aMAT had a genomic inflation factor of 1.04, indicating the Type I error rates were well controlled. More important, aMAT identified 24 distinct risk loci, 13 of which were ignored by standard GWAS. In comparison, the competing methods either had a suspicious genomic inflation factor or identified much fewer risk loci. Finally, four additional sets of traits have been analyzed and provided similar conclusions.

scholarly journals Power Analysis Provides Bounds for Genetic Architecture and Insights to Challenges for Rare Variant Association Studies

2017 ◽  
Author(s):  
Andriy Derkach ◽  
Haoyu Zhang ◽  
Nilanjan Chatterjee
Keyword(s):  
Power Analysis ◽  
Genetic Architecture ◽  
Rare Variants ◽  
Association Studies ◽  
Power Calculation ◽  
Genome Wide Association Studies ◽  
Meaningful Improvement ◽  
Association Tests ◽  
Genome Wide ◽  
A Genome

AbstractGenome-wide association studies are now shifting focus from analysis of common to uncommon and rare variants with an anticipation to explain additional heritability of complex traits. As power for association testing for individual rare variants may often be low, various aggregate level association tests have been proposed to detect genetic loci that may contain clusters of susceptibility variants. Typically, power calculations for such tests require specification of large number of parameters, including effect sizes and allele frequencies of individual variants, making them difficult to use in practice. In this report, we approximate power to varying degree of accuracy using a smaller number of key parameters, including the total genetic variance explained by multiple variants within a locus. We perform extensive simulation studies to assess the accuracy of the proposed approximations in realistic settings. Using the simplified power calculation methods, we then develop an analytic framework to obtain bounds on genetic architecture of an underlying trait given results from a genome-wide study and observe important implications for the completely lack of or limited number of findings in many currently reported studies. Finally, we provide insights into the required quality of annotation/functional information for identification of likely causal variants to make meaningful improvement in power of subsequent association tests. A shiny application, Power Analysis for GEnetic AssociatioN Tests (PAGEANT), in R implementing the methods is made publicly available.

Sign in / Sign up

Export Citation Format

Share Document